Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca C Coll

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Solution structure of the TLR adaptor MAL/TIRAP reveals an intact BB loop and supports MAL Cys91 glutathionylation for signalingMark M Hughes, Peter Lavrencic, Rebecca C Coll, et al.
Nature Chemical Biology|May 16, 2019
MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibitionRebecca C Coll, James R Hill, Christopher J Day, et al.
Chemmedchem|July 14, 2017
Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome InhibitorsJames R Hill, Rebecca C Coll, Nancy Sue, et al.
The Journal of Experimental Medicine|February 13, 2018
Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activityDave Boucher, Mercedes Monteleone, Rebecca C Coll, et al.
Thorax|December 26, 2023
Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS)Puja Mehta, Romit J Samanta, Katherine Wick, et al.
Science Signaling|January 23, 2024
NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasomeJared R Coombs, Alina Zamoshnikova, Caroline L Holley, et al.
Cell Reports|September 15, 2024
Butyrate and propionate are microbial danger signals that activate the NLRP3 inflammasome in human macrophages upon TLR stimulationWei Wang, Alesja Dernst, Bianca Martin, et al.
Brain : a Journal of Neurology|October 16, 2025
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease modelsEduardo A Albornoz, Karine Mardon, Rajiv Bhalla, et al.
Arthritis Research & Therapy|September 2, 2014
Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destructionClaire J Greenhill, Gareth W Jones, Mari A Nowell, et al.
Blood|October 15, 2016
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotypeAshley A Basiorka, Kathy L McGraw, Erika A Eksioglu, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2017
Solution structure of the TLR adaptor MAL/TIRAP reveals an intact BB loop and supports MAL Cys91 glutathionylation for signalingMark M Hughes, Peter Lavrencic, Rebecca C Coll, et al.
Nature Chemical Biology|May 16, 2019
MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibitionRebecca C Coll, James R Hill, Christopher J Day, et al.
Chemmedchem|July 14, 2017
Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome InhibitorsJames R Hill, Rebecca C Coll, Nancy Sue, et al.
The Journal of Experimental Medicine|February 13, 2018
Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activityDave Boucher, Mercedes Monteleone, Rebecca C Coll, et al.
Thorax|December 26, 2023
Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS)Puja Mehta, Romit J Samanta, Katherine Wick, et al.
Science Signaling|January 23, 2024
NLRP12 interacts with NLRP3 to block the activation of the human NLRP3 inflammasomeJared R Coombs, Alina Zamoshnikova, Caroline L Holley, et al.
Cell Reports|September 15, 2024
Butyrate and propionate are microbial danger signals that activate the NLRP3 inflammasome in human macrophages upon TLR stimulationWei Wang, Alesja Dernst, Bianca Martin, et al.
Brain : a Journal of Neurology|October 16, 2025
PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson's disease modelsEduardo A Albornoz, Karine Mardon, Rajiv Bhalla, et al.
Arthritis Research & Therapy|September 2, 2014
Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destructionClaire J Greenhill, Gareth W Jones, Mari A Nowell, et al.
Blood|October 15, 2016
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotypeAshley A Basiorka, Kathy L McGraw, Erika A Eksioglu, et al.
Pageof 4